Back to today’s briefing

Story perspectives

New Stem Cell Therapy Boosts ALS Survival Rates Dramatically

7/24/2025

28 6

Summary

Story summary

A groundbreaking study by Prof. Dimitrios Karussis at Hadassah Medical Organization reveals that NG01, a revolutionary stem cell therapy, significantly enhances survival rates for ALS patients. In a remarkable 15-year observation of 20 individuals, the median survival soared to 7.2 years, with nearly half living beyond a decade. These promising results pave the way for larger trials to validate this hope.

1 of 1

Story summary

A groundbreaking study by Prof. Dimitrios Karussis at Hadassah Medical Organization reveals that NG01, a revolutionary stem cell therapy, significantly enhances survival rates for ALS patients. In a remarkable 15-year observation of 20 individuals, the median survival soared to 7.2 years, with nearly half living beyond a decade. These promising results pave the way for larger trials to validate this hope.